Used as a key chiral intermediate in the synthesis of biologically active compounds, particularly in pharmaceuticals targeting neurological and psychiatric disorders. Its structure supports the development of agents that modulate neurotransmitter activity, making it valuable in the research and production of selective receptor agonists or antagonists. The compound’s stereochemistry enhances binding specificity, improving the efficacy and safety profile of the final drug products. It is also employed in the preparation of enzyme inhibitors and receptor modulators in medicinal chemistry research.